Magnetic resonance imaging of the breast: Current indications

Canadian Association of Radiologists Journal

Volumn 56, Issue 5, 2005, Pages 301-308

  Lalonde, Lucie ^a,b   David, Julie ^a   Trop, Isabelle ^a  

^a Centre d'Imagerie du Sein   (Canada)

^b Clinique Leger et Associes   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE GEL;

AXILLARY LYMPH NODE; BREAST CANCER; BREAST ENDOPROSTHESIS; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; CHEMOTHERAPY; DIAGNOSTIC VALUE; HUMAN; MAMMOGRAPHY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PARTIAL MASTECTOMY; PATHOLOGY; PREOPERATIVE CARE; RADIOLOGIST; RECURRENT DISEASE; RELIABILITY; REVIEW; SCAR; TUMOR;

AXILLA; BIOPSY; BREAST; BREAST IMPLANTS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, UNKNOWN PRIMARY; PATIENT SELECTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SILICONE GELS; SILICONES; SURVIVAL ANALYSIS;

EID: 32544438020     PISSN: 08465371     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Bartella L, Dershaw DD. Magnetic resonance imaging of invasive breast carcinoma. In: Morris EA, Liberman L, editors. Breast MRI: diagnosis and intervention. New York (NY): Springer; 2005. p 173-83.
2. Helvie MA. Imaging analysis: mammography. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Disease of the breast. Philadelphia (PA): Lippincott Williams and Wilkins; 2004. p 131-48.
3. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
4. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fischer ER, et al. Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
5. Davis PL, Staiger MJ, Harris KB, Ganott MA, Klementaviciene J, McCarty JS Jr, et al. Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat 1996;37:1-9.
6. Weinstein SP, Orel SG, Heller R,Reynolds C, Czerniecki B, Lawrence J, et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 2001;176:399-406.
7. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999;17:110-9.
8. Morris E. Cancer staging with breast MR imaging. Magn Reson Imaging Clin N Am 2001;9:333-44.
9. Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004;14:1725-31.
10. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of the breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 2002;20:3413-23.
11. Mennel JH. Ductal carcinoma in situ. In: Morris EA, Liberman I, editors. Breast MRI: diagnosis and intervention. New York (NY): Springer; 2005. p 164-72.
12. Hwang ES, Kinkel K, Esserman L, Lu Y, Weidner N, Hylton NM, et al. Magnetic resonance imaging in patients diagnosed with ductal carcinoma in situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 2003;10:381-8.
13. Kothari AD, Beechey-Newman N, Hamed H, Fentiman IS, D'Arrigo C, Hanby AM, et al. Paget disease of the nipple, a multifocal manifestation of higher-risk disease. Cancer 2002;95:1-7.
14. Frei KA, Bonel HM, Pelte MF, Hylton NM, Kinkel K. Paget disease of the breast: Findings at magnetic resonance imaging and histopathologic correlation. Invest Radiol 2005;40:363-7.
15. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of the breast cancer. Radiology 2001;220:13-30.
16. Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Hwang S, et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 2001;8:549-59.
17. Frei KA, Kinkel K, Bonel HM, Lu T, Esserman LJ, Hylton NM. MR imaging of the breast in patients with positive margins after lumpectomy; influence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol 2000;175:1577-84.
18. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky DA, Hylton NM. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002;179:1193-209.
19. Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kuhn T. Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol 2002;12:1711-9.
20. Meisamy S, Bolan PJ, Baker EH, Bliss RL, Gulbahce E, Everson LI, et al. Neoadjuvant Chemotherapy of locally advanced breast cancer: predicting response with in vivo H MR Spectroscopy-A pilot study at 4 T. Radiology 2004;233:424-31.
21. Morris EA, Schwartz LH, Dershaw DD, Van Zee KJ, Abramson AF, Liberman L. MR Imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997;205:437-40.
22. Olson JA Jr, Morris EA, Van Zee KJLinehan DC, Borgen PI. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000;7:411-5.
23. Liberman L. Breast cancer screening with MRI. What are the data for the patients at high-risk. N Engl J Med 2004;351:497-500.
24. Goodman CM, Cohen V, Thornyby J, Netscher D. The life span of silicone gel breast implants and a comparison of mammography, ultrasonography, and MRI in detecting implant rupture: a meta-analysis. Ann Plast Surg 1998;41:577-86.